Management of Chronic Daily Headache with Focus on Botulinum Toxin Type
Goal: The purpose of the study was to review the efficacy, safety
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
Goal: The purpose of the study was to review the efficacy, safety
Background: First bite syndrome is the reported development of pain in the
disadvantages. Botulinum toxin type A is licensed for the treatment of axillary hyperhidrosis but is now being used to treat several other types of focal hyperhidrosis. Botulinum toxins exert their ... acetylcholine…
this study is to determine the clinical efficacy of different drugs (Baimai ointment, botulinum toxin type A) in the treatment of spastic cerebral palsy in children with pointed feet ... research group was given Baimai…
bifida, cerebral palsy, and spinal cord injuries. When conventional treatments prove inadequate, intravesical botulinum toxin type A pharmacotherapy has emerged as a promising intervention. This article explores the…
significant improvements, we are faced with a gingival smile in this type of patient. The application of botulinum toxin has the property of muscle relaxation. The purpose of this explanation
Botulinum toxin Type A (BTA) is the most popular nonsurgical aesthetic treatment worldwide. With the constantly evolving injection techniques, what was considered state-of-the-art 5-10 years ... longer represents the…
Impotancce of Botulinum Toxin Type A The restorative form of eubacteria poison, currently and so alluded to as "Botox" by patients, is also a renowned injectable that in short diminishes ... like thick teams among the…
Background: Botulinum toxin type A (BoNT-A) has been used in treating dysphagia due to spasticity of upper oesophageal sphincter (UES). However, the doses commonly injected could result ineffective
Objective: Botulinum toxin type A (BTX-A) use reduces upper limb (UL) spasticity in stroke patients, but the effects on functional recovery remain uncertain. The aim of present review
ntramuscular Botulinum toxin type A (BTX) injections reduce spasticity in children with cerebral palsy (CP) by blocking neurotransmission at the motor end plates (MEP). Goal of this study
Background: The botulinum toxin type A (BoNT-A) is is safe and effective treatment that is used in diverse range of in neurologic diseases. Patients satisfaction may affect successful treatment
Background: Considered once the most toxic substance in the world, botulinum toxin (BTX) is presently under a more engaging day. Its medical use has gained an important extension ... visual numeric scale (VNS), with or…
Goal: The purpose of the study was to review the efficacy, safety
Acute Respiratory Distress Syndrome (ARDS), which is seen in adults and can
Introduction: Pisa syndrome (PS) is a lateral axial dystonia (LAD) characterized by
Objective: To investigate the risk factors for, and the incidence of, structural
varying effects. Many reports show that the most effective method is to inject botulinum toxin, type A (BTX-A) into the spasming muscles, but the doses are different. The guidline
Cervical dystonia, also referred to as spasmodic torticollis, is the most frequent
Several treatments have been proposed for the management of spasticity. The injection of botulinum toxin type A is considered the gold standard treatment and appears to be safe and effective ... combination between…
For authors and organisers
Find the right journal for your paper and submit your manuscript.